机译:失餐的miR-137及其目标EGFR有助于垂体腺瘤的进展
Tangshan Peoples Hosp Dept Neurosurg Tangshan Hebei Peoples R China;
Tangshan Peoples Hosp Dept Crit Care Med Tangshan Hebei Peoples R China;
Tangshan Peoples Hosp Dept Neurosurg Tangshan Hebei Peoples R China;
Tangshan Caofeidian Dist Hosp Dept Neurosurg Tangshan Hebei Peoples R China;
Tangshan Peoples Hosp Dept Crit Care Med Tangshan Hebei Peoples R China;
Capital Med Univ Beijing Neurosurg Inst Beijing Peoples R China;
Tangshan Peoples Hosp Dept Oncol Tangshan Hebei Peoples R China;
Pituitary adenoma (PA); Epidermal growth factor receptor (EGFR); miR-137; Tyrosine kinase inhibitors (TKIs); AZD9291;
机译:MicroRNA miR-137的表达表达及其目标YBX1有助于恶性胸膜间皮瘤的侵袭性特征
机译:MIR-137的MIR-137的MECP2介导的表观遗传沉默有助于通过缓解C-MET的抑制来达到结肠直肠腺瘤 - 癌序列和肿瘤进展
机译:miR-212的减少有助于通过靶向c-met垂直腺瘤细胞侵袭
机译:用高清视频望远镜垂直依赖高肾上腺皮质溶胶犬脑垂体手术犬脑垂体手术:方法和结果
机译:结肠腺瘤起始和进展的两步模型,在apc丧失后需要CtBP1和KRAS。
机译:Mecp2介导的miR-137的表观遗传沉默有助于大肠腺瘤-癌序列和通过减轻c-Met抑制的肿瘤进展。
机译:MIR-137的MIR-137的MECP2介导的表观遗传沉默有助于通过缓解C-MET的抑制来达到结肠直肠腺瘤 - 癌序列和肿瘤进展
机译:初步提交:aluminium Co amer致UsEpa的信:关于:Warrick手术中4名工人的垂体腺瘤诊断印第安纳州纽堡的冶炼厂日期:04/05/1995